Image_1_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF حسب Zhixing Kuang (10809975)

"…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …"

Image 2_Serum neuritin as a predictive biomarker of early neurological deterioration and poor prognosis after spontaneous intracerebral hemorrhage: a prospective cohort study.tif حسب Yanwen Xu (663813)

"…END was defined as a decrease of ≥2 points in the GCS score within 24 h of admission. …"

Image 10_Serum neuritin as a predictive biomarker of early neurological deterioration and poor prognosis after spontaneous intracerebral hemorrhage: a prospective cohort study.tif حسب Yanwen Xu (663813)

"…END was defined as a decrease of ≥2 points in the GCS score within 24 h of admission. …"

Image_7_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF حسب Zhixing Kuang (10809975)

"…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …"

Table_1_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.xls حسب Zhixing Kuang (10809975)

"…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …"

Image 9_Serum neuritin as a predictive biomarker of early neurological deterioration and poor prognosis after spontaneous intracerebral hemorrhage: a prospective cohort study.tif حسب Yanwen Xu (663813)

"…END was defined as a decrease of ≥2 points in the GCS score within 24 h of admission. …"

Image 12_Serum neuritin as a predictive biomarker of early neurological deterioration and poor prognosis after spontaneous intracerebral hemorrhage: a prospective cohort study.tif حسب Yanwen Xu (663813)

"…END was defined as a decrease of ≥2 points in the GCS score within 24 h of admission. …"

Image_8_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF حسب Zhixing Kuang (10809975)

"…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …"

Image 11_Serum neuritin as a predictive biomarker of early neurological deterioration and poor prognosis after spontaneous intracerebral hemorrhage: a prospective cohort study.tiff حسب Yanwen Xu (663813)

"…END was defined as a decrease of ≥2 points in the GCS score within 24 h of admission. …"

Image_4_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF حسب Zhixing Kuang (10809975)

"…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …"

Image 8_Serum neuritin as a predictive biomarker of early neurological deterioration and poor prognosis after spontaneous intracerebral hemorrhage: a prospective cohort study.tif حسب Yanwen Xu (663813)

"…END was defined as a decrease of ≥2 points in the GCS score within 24 h of admission. …"

Image 1_Serum neuritin as a predictive biomarker of early neurological deterioration and poor prognosis after spontaneous intracerebral hemorrhage: a prospective cohort study.tif حسب Yanwen Xu (663813)

"…END was defined as a decrease of ≥2 points in the GCS score within 24 h of admission. …"

Table 1_Serum neuritin as a predictive biomarker of early neurological deterioration and poor prognosis after spontaneous intracerebral hemorrhage: a prospective cohort study.doc حسب Yanwen Xu (663813)

"…END was defined as a decrease of ≥2 points in the GCS score within 24 h of admission. …"

Image 5_Serum neuritin as a predictive biomarker of early neurological deterioration and poor prognosis after spontaneous intracerebral hemorrhage: a prospective cohort study.tif حسب Yanwen Xu (663813)

"…END was defined as a decrease of ≥2 points in the GCS score within 24 h of admission. …"

Image_6_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF حسب Zhixing Kuang (10809975)

"…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …"

Image 13_Serum neuritin as a predictive biomarker of early neurological deterioration and poor prognosis after spontaneous intracerebral hemorrhage: a prospective cohort study.tif حسب Yanwen Xu (663813)

"…END was defined as a decrease of ≥2 points in the GCS score within 24 h of admission. …"

Sox2 direct interaction with mouse <i>Huwe1</i> and human <i>Huwe1</i> genes. حسب Yen-Fu Cheng (5819855)

ICD- and CHOP-codes of selected procedures. حسب Brigitte Wirth (4925977)

"…With procedure-specific decreases of up to 86%, the decline in admissions was largest for elective surgery, a decline that was only fully reversed in the case of a few procedures, such as joint arthroplasty. …"

Summary of treatments for the gene expression study (Experiment 3). حسب Amberleigh E. Henschen (3257235)

Angiotensin Converting Enzyme Inhibitor and HMG-CoA Reductase Inhibitor as Adjunct Treatment for Persons with HIV Infection: <em>A Feasibility Randomized Trial</em> حسب Jason V. Baker (127530)

"…</p> <h3>Design and Methods</h3><p>We conducted a 2×2 factorial feasibility study of lisinopril (L) (10 mg daily) vs L-placebo in combination with pravastatin (P) (20 mg daily) vs P-placebo among participants receiving ART with undetectable HIV RNA levels, a Framingham 10 year risk score (FRS) ≥3%, and no indication for ACE-I or statin therapy. …"